Simon Tavaré joined Columbia University in 2018 as founding director of the Irving Institute for Cancer Dynamics and professor in the Departments of Statistics and Biological Sciences.
Dr. Tavaré obtained his Ph.D. in Probability and Statistics in 1979 from the University of Sheffield and began his research career in the USA at the University of Utah and with Sam Karlin at Stanford. He subsequently held positions in Statistics at Colorado State University, Mathematics at the University of Utah, and Mathematics and Biology at the University of Southern California. He held the Kawamoto Chair in Biological Sciences at USC from 1998 to 2014. His research at USC included work in computational statistics, bioinformatics, population genetics, probabilistic combinatorics, and inference for stochastic processes.
In 2003, Dr. Tavaré moved to the University of Cambridge, as professor of cancer research in the Department of Oncology, a group leader in Cancer Research UK’s Cambridge Research Institute from 2006, and a professor in the Department of Applied Mathematics and Theoretical Physics, where he was director of the Wellcome Trust Ph.D. program in Mathematical Genomics and Medicine, and director of its MPhil in computational biology.
From February 2013 to January 2018, he was director of the (renamed) Cancer Research UK Cambridge Institute, which had become a department of the University of Cambridge in January 2013. His research focused on statistical bioinformatics and computational biology, particularly evolutionary approaches to understanding cancer biology. In 2009, Dr. Tavaré was elected a Fellow of the Academy of Medical Sciences (FMedSci), in 2011 a Fellow of the Royal Society (FRS), and in 2015 a member of EMBO. He gave the American Mathematical Society’s Einstein Lecture in 2015 and was one of the invited speakers at ICIAM2015 in Beijing. He was president of the London Mathematical Society from 2015 to 2017 and was elected a Fellow of the American Mathematical Society and an International Member of the U.S. National Academy of Sciences in 2018.
At Columbia, as Irving Professor of Cancer Research, he will continue his work on cancer dynamics, statistical bioinformatics, and methods for understanding the three-dimensional structure of solid tumors at single-cell resolution, this last through membership of the CRUK Grand Challenge IMAXT project coordinated from Cambridge.